Treatment of acute myeloblastic leukaemia with RP 22050.
D000328:Adult; D002648:Child; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin; D004351:Drug Resistance; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013997:Time Factors
D004317:Doxorubicin; D003630:Daunorubicin